Amlodipine Besylate Tablet
Product Images NDC 0904-6370

6 FDA label images from Major Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 0904-6370). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structured Formula For Amlodipine (36812bc2 E5a7 4241 95d0 1e015ddbaf29 01)

Structured Formula For Amlodipine (36812bc2 E5a7 4241 95d0 1e015ddbaf29 01)
Chemical structure of Amlodipine Besylate, depicting its molecular configuration with various functional groups and atom connectivity.*
FDA Label Image

Structured Formula For Amlodipine (36812bc2 E5a7 4241 95d0 1e015ddbaf29 02)

Structured Formula For Amlodipine (36812bc2 E5a7 4241 95d0 1e015ddbaf29 02)
A Kaplan-Meier curve graph comparing event rates over time in months for Amlodipine versus placebo. The graph shows lower event rates for Amlodipine, with risk numbers decreasing over 24 months. Statistical data includes a p-value of 0.003 and a hazard ratio of 0.691 (95% CI: 0.54 to 0.88).*
FDA Label Image

Structured Formula For Amlodipine (36812bc2 E5a7 4241 95d0 1e015ddbaf29 03)

Structured Formula For Amlodipine (36812bc2 E5a7 4241 95d0 1e015ddbaf29 03)
A forest plot chart displaying hazard ratios with 95% confidence intervals comparing amlodipine versus placebo across several patient subgroups. Subgroups include overall patients, age groups below and above 85, gender, baseline sitting systolic blood pressure (SBP) relative to mean, baseline vessel disease, baseline vessels with stenosis, and PCI-stent strata. The horizontal axis ranges from 0.0 to 2.0, indicating the effect direction favoring either amlodipine or placebo.*
FDA Label Image

2.5mg Carton Label (3e9e049d A988 4dc5 B9aa 14f1162409d6 02)

2.5mg Carton Label (3e9e049d A988 4dc5 B9aa 14f1162409d6 02)
Packaging label for Amlodipine Besylate 2.5 mg tablets, USP, oral dosage form, distributed by Major Pharmaceuticals. The label indicates a unit dose package containing 100 tablets (10 x 10) with NDC 0904-6369-61. Instructions note dispensing with patient information leaflets and storage at controlled room temperature. The label states the product is Rx only and includes warnings to keep out of reach of children, intended for institutional use only.*
FDA Label Image

5mg Carton Label (3e9e049d A988 4dc5 B9aa 14f1162409d6 01)

5mg Carton Label (3e9e049d A988 4dc5 B9aa 14f1162409d6 01)
Packaging label for Amlodipine Besylate 5 mg tablets, USP by Major Pharmaceuticals. This unit dose package contains 100 tablets (10 x 10), labeled with NDC 0904-6370-61. The label includes dispensing instructions, storage conditions, usage warnings, and manufacturer information.*
FDA Label Image

10mg Carton Label (3e9e049d A988 4dc5 B9aa 14f1162409d6 00)

10mg Carton Label (3e9e049d A988 4dc5 B9aa 14f1162409d6 00)
Label for Amlodipine Besylate 10 mg oral tablets from Major Pharmaceuticals. The label indicates unit dose packaging with 100 tablets (10 x 10), includes NDC 0904-6371-61, and states prescription-only status. It features usage instructions for pharmacists and storage conditions, along with distributor information and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.